<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1999-07-15" modified="2020-10-07" version="190">
<accession>O15055</accession>
<accession>A2I2P7</accession>
<accession>Q4ZG49</accession>
<accession>Q6DT41</accession>
<accession>Q9UQ45</accession>
<name>PER2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Period circadian protein homolog 2</fullName>
<shortName>hPER2</shortName>
</recommendedName>
<alternativeName>
<fullName>Circadian clock protein PERIOD 2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PER2</name>
<name type="synonym">KIAA0347</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="submission" date="1998-03" db="EMBL/GenBank/DDBJ databases">
<title>cDNA cloning and characterization of Per2S, an alternatively spliced human Per2 variant.</title>
<authorList>
<person name="Ikeda M."/>
<person name="Takehara N."/>
<person name="Ebisawa T."/>
<person name="Yamauchi T."/>
<person name="Nomura M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2001" name="FEBS Lett." volume="489" first="159" last="165">
<title>Human casein kinase Idelta phosphorylation of human circadian clock proteins period 1 and 2.</title>
<authorList>
<person name="Camacho F."/>
<person name="Cilio M."/>
<person name="Guo Y."/>
<person name="Virshup D.M."/>
<person name="Patel K."/>
<person name="Khorkova O."/>
<person name="Styren S."/>
<person name="Morse B."/>
<person name="Yao Z."/>
<person name="Keesler G.A."/>
</authorList>
<dbReference type="PubMed" id="11165242"/>
<dbReference type="DOI" id="10.1016/s0014-5793(00)02434-0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH CSNK1D</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2006-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="DNA Res." volume="4" first="141" last="150">
<title>Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Nakajima D."/>
<person name="Ohira M."/>
<person name="Seki N."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="9205841"/>
<dbReference type="DOI" id="10.1093/dnares/4.2.141"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="1999-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Seki N."/>
<person name="Nakajima D."/>
<person name="Ohira M."/>
<person name="Miyajima N."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO C-TERMINUS</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2004-06" db="EMBL/GenBank/DDBJ databases">
<title>A single-nucleotide polymorphism in the 5'-untranslated region of the hPER2 gene is associated with diurnal preference.</title>
<authorList>
<person name="Carpen J.D."/>
<person name="Archer S.N."/>
<person name="Skene D.J."/>
<person name="Smits M."/>
<person name="von Schantz M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-65</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Neuron" volume="19" first="1261" last="1269">
<title>Two period homologs: circadian expression and photic regulation in the suprachiasmatic nuclei.</title>
<authorList>
<person name="Shearman L.P."/>
<person name="Zylka M.J."/>
<person name="Weaver D.R."/>
<person name="Kolakowski L.F. Jr."/>
<person name="Reppert S.M."/>
</authorList>
<dbReference type="PubMed" id="9427249"/>
<dbReference type="DOI" id="10.1016/s0896-6273(00)80417-1"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Biochem. J." volume="380" first="95" last="103">
<title>Phosphorylation of clock protein PER1 regulates its circadian degradation in normal human fibroblasts.</title>
<authorList>
<person name="Miyazaki K."/>
<person name="Nagase T."/>
<person name="Mesaki M."/>
<person name="Narukawa J."/>
<person name="Ohara O."/>
<person name="Ishida N."/>
</authorList>
<dbReference type="PubMed" id="14750904"/>
<dbReference type="DOI" id="10.1042/bj20031308"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2012" name="EMBO J." volume="31" first="1427" last="1439">
<title>PML regulates PER2 nuclear localization and circadian function.</title>
<authorList>
<person name="Miki T."/>
<person name="Xu Z."/>
<person name="Chen-Goodspeed M."/>
<person name="Liu M."/>
<person name="Van Oort-Jansen A."/>
<person name="Rea M.A."/>
<person name="Zhao Z."/>
<person name="Lee C.C."/>
<person name="Chang K.S."/>
</authorList>
<dbReference type="PubMed" id="22274616"/>
<dbReference type="DOI" id="10.1038/emboj.2012.1"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PML</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2014" name="Cell. Mol. Life Sci." volume="71" first="2547" last="2559">
<title>Nucleolar localization and circadian regulation of Per2S, a novel splicing variant of the Period 2 gene.</title>
<authorList>
<person name="Avitabile D."/>
<person name="Genovese L."/>
<person name="Ponti D."/>
<person name="Ranieri D."/>
<person name="Raffa S."/>
<person name="Calogero A."/>
<person name="Torrisi M.R."/>
</authorList>
<dbReference type="PubMed" id="24202686"/>
<dbReference type="DOI" id="10.1007/s00018-013-1503-1"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY (ISOFORM 2)</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2013" name="Physiol. Rev." volume="93" first="107" last="135">
<title>Metabolism and the circadian clock converge.</title>
<authorList>
<person name="Eckel-Mahan K."/>
<person name="Sassone-Corsi P."/>
</authorList>
<dbReference type="PubMed" id="23303907"/>
<dbReference type="DOI" id="10.1152/physrev.00016.2012"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2014" name="Trends Cell Biol." volume="24" first="90" last="99">
<title>Molecular architecture of the mammalian circadian clock.</title>
<authorList>
<person name="Partch C.L."/>
<person name="Green C.B."/>
<person name="Takahashi J.S."/>
</authorList>
<dbReference type="PubMed" id="23916625"/>
<dbReference type="DOI" id="10.1016/j.tcb.2013.07.002"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2018" name="Proc. Natl. Acad. Sci. U.S.A." volume="115" first="E12305" last="E12312">
<title>Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks.</title>
<authorList>
<person name="Qu M."/>
<person name="Duffy T."/>
<person name="Hirota T."/>
<person name="Kay S.A."/>
</authorList>
<dbReference type="PubMed" id="30530698"/>
<dbReference type="DOI" id="10.1073/pnas.1816411115"/>
</citation>
<scope>INTERACTION WITH HNF4A</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="Science" volume="291" first="1040" last="1043">
<title>An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome.</title>
<authorList>
<person name="Toh K.L."/>
<person name="Jones C.R."/>
<person name="He Y."/>
<person name="Eide E.J."/>
<person name="Hinz W.A."/>
<person name="Virshup D.M."/>
<person name="Ptacek L.J."/>
<person name="Fu Y.-H."/>
</authorList>
<dbReference type="PubMed" id="11232563"/>
<dbReference type="DOI" id="10.1126/science.1057499"/>
</citation>
<scope>VARIANT FASPS1 GLY-662</scope>
<scope>PHOSPHORYLATION AT SER-662</scope>
<scope>MUTAGENESIS OF SER-662</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] VAL-823</scope>
</reference>
<comment type="function">
<text evidence="3">Transcriptional repressor which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndrome and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress ARNTL/BMAL1 transcription, respectively. PER1 and PER2 proteins transport CRY1 and CRY2 into the nucleus with appropriate circadian timing, but also contribute directly to repression of clock-controlled target genes through interaction with several classes of RNA-binding proteins, helicases and others transcriptional repressors. PER appears to regulate circadian control of transcription by at least three different modes. First, interacts directly with the CLOCK-ARTNL/BMAL1 at the tail end of the nascent transcript peak to recruit complexes containing the SIN3-HDAC that remodel chromatin to repress transcription. Second, brings H3K9 methyltransferases such as SUV39H1 and SUV39H2 to the E-box elements of the circadian target genes, like PER2 itself or PER1. The recruitment of each repressive modifier to the DNA seems to be very precisely temporally orchestrated by the large PER complex, the deacetylases acting before than the methyltransferases. Additionally, large PER complexes are also recruited to the target genes 3' termination site through interactions with RNA-binding proteins and helicases that may play a role in transcription termination to regulate transcription independently of CLOCK-ARTNL/BMAL1 interactions. Recruitment of large PER complexes to the elongating polymerase at PER and CRY termination sites inhibited SETX action, impeding RNA polymerase II release and thereby repressing transcriptional reinitiation. May propagate clock information to metabolic pathways via the interaction with nuclear receptors. Coactivator of PPARA and corepressor of NR1D1, binds rhythmically at the promoter of nuclear receptors target genes like ARNTL or G6PC. Directly and specifically represses PPARG proadipogenic activity by blocking PPARG recruitment to target promoters and thereby inhibiting transcriptional activation. Required for fatty acid and lipid metabolism, is involved as well in the regulation of circulating insulin levels. Plays an important role in the maintenance of cardiovascular functions through the regulation of NO and vasodilatatory prostaglandins production in aortas. Controls circadian glutamate uptake in synaptic vesicles through the regulation of VGLUT1 expression. May also be involved in the regulation of inflammatory processes. Represses the CLOCK-ARNTL/BMAL1 induced transcription of BHLHE40/DEC1 and ATF4. Negatively regulates the formation of the TIMELESS-CRY1 complex by competing with TIMELESS for binding to CRY1.</text>
</comment>
<comment type="subunit">
<text evidence="3 6 10 12">Homodimer. Component of the circadian core oscillator, which includes the CRY proteins, CLOCK or NPAS2, ARTNL/BMAL1 or ARTNL2/BMAL2, CSNK1D and/or CSNK1E, TIMELESS, and the PER proteins. Interacts with CLOCK-ARNTL/BMAL1 (off DNA).Interacts with ARNTL2/BMAL2. Interacts directly with PER1 and PER3, and through a C-terminal domain, with CRY1 and CRY2. Interacts, via its second PAS domain, with TIMELESS in vitro. Interacts with NFIL3. Different large complexes have been identified with different repressive functions. The core of PER complexes is composed of at least PER1, PER2, PER3, CRY1, CRY2, CSNK1D and/or CSNK1E. The large PER complex involved in the repression of transcriptional termination is composed of at least PER2, CDK9, DDX5, DHX9, NCBP1 and POLR2A (active). The large PER complex involved in the histone deacetylation is composed of at least HDAC1, PER2, SFPQ and SIN3A. The large PER complex involved in the histone methylation is composed of at least PER2, CBX3, TRIM28, SUV39H1 and/or SUV39H2; CBX3 mediates the formation of the complex. Interacts with SETX; the interaction inhibits termination of circadian target genes. Interacts with the nuclear receptors HNF4A, NR1D1, NR4A2, RORA, PPARA, PPARG and THRA; the interaction with at least PPARG is ligand dependent. Interacts with PML. Interacts (phosphorylated) with BTRC and FBXW11; the interactions trigger proteasomal degradation. Interacts with NONO and SFPQ. Interacts with SIRT1 and CAVIN3 (By similarity). Interacts with MAGEL2 (By similarity). Interacts with MAP1LC3B (By similarity). Interacts with HNF4A (PubMed:30530698).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054296">
<id>O15055</id>
</interactant>
<interactant intactId="EBI-751621">
<id>P48730</id>
<label>CSNK1D</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054296">
<id>O15055</id>
</interactant>
<interactant intactId="EBI-749343">
<id>P49674</id>
<label>CSNK1E</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054296">
<id>O15055</id>
</interactant>
<interactant intactId="EBI-742350">
<id>Q14241</id>
<label>ELOA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054296">
<id>O15055</id>
</interactant>
<interactant intactId="EBI-739546">
<id>Q96PV6</id>
<label>LENG8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054296">
<id>O15055</id>
</interactant>
<interactant intactId="EBI-2798728">
<id>P61968</id>
<label>LMO4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054296">
<id>O15055</id>
</interactant>
<interactant intactId="EBI-744248">
<id>P40692</id>
<label>MLH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054296">
<id>O15055</id>
</interactant>
<interactant intactId="EBI-10178671">
<id>J3QSH9</id>
<label>PER1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054296">
<id>O15055</id>
</interactant>
<interactant intactId="EBI-295890">
<id>P29590</id>
<label>PML</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1054296">
<id>O15055</id>
</interactant>
<interactant intactId="EBI-356983">
<id>P11441</id>
<label>UBL4A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="3">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="2">Cytoplasm</location>
<location evidence="2">Perinuclear region</location>
</subcellularLocation>
<text>Nucleocytoplasmic shuttling is effected by interaction with other circadian core oscillator proteins and/or by phosphorylation. Translocate to the nucleus after phosphorylation by CSNK1D or CSNK1E. Also translocated to the nucleus by CRY1 or CRY2. PML regulates its nuclear localization.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="11">Nucleus</location>
<location evidence="11">Nucleolus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O15055-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O15055-2</id>
<name>2</name>
<name>PER2S</name>
<sequence type="described" ref="VSP_021653 VSP_021654"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13">Widely expressed. Found in heart, brain, placenta, lung, liver, skeleatal muscle, kidney and pancreas. High levels in skeletal muscle and pancreas. Low levels in lung. Isoform 2 is expressed in keratinocytes (at protein level).</text>
</comment>
<comment type="induction">
<text evidence="8">Oscillates diurnally. Rhythmic levels are critical for the generation of circadian rhythms in central as well as peripheral clocks. Targeted degradation of PER and CRY proteins enables the reactivation of CLOCK-ARTNL/BMAL1, thus initiating a new circadian transcriptional cycle with an intrinsic period of 24 hours.</text>
</comment>
<comment type="PTM">
<text evidence="3">Acetylated. Deacetylated by SIRT1, resulting in decreased protein stability.</text>
</comment>
<comment type="PTM">
<text evidence="6 7">Phosphorylated by CSNK1E and CSNK1D. Phosphorylation results in PER2 protein degradation. May be dephosphorylated by PP1.</text>
</comment>
<comment type="PTM">
<text evidence="3">Ubiquitinated, leading to its proteasomal degradation. Ubiquitination may be inhibited by CRY1.</text>
</comment>
<comment type="disease" evidence="7">
<disease id="DI-01548">
<name>Advanced sleep phase syndrome, familial, 1</name>
<acronym>FASPS1</acronym>
<description>A disorder characterized by very early sleep onset and offset. Individuals are 'morning larks' with a 4 hours advance of the sleep, temperature and melatonin rhythms.</description>
<dbReference type="MIM" id="604348"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="15">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA20804" version="2"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EMBL" id="AB012614">
<property type="protein sequence ID" value="BAA83709.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF015905">
<property type="protein sequence ID" value="ABM64216.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB002345">
<property type="protein sequence ID" value="BAA20804.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC012485">
<property type="protein sequence ID" value="AAX88976.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471063">
<property type="protein sequence ID" value="EAW71155.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY647991">
<property type="protein sequence ID" value="AAT68170.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2528.1">
<molecule id="O15055-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_073728.1">
<molecule id="O15055-1"/>
<property type="nucleotide sequence ID" value="NM_022817.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005246168.1">
<molecule id="O15055-1"/>
<property type="nucleotide sequence ID" value="XM_005246111.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006712887.1">
<molecule id="O15055-1"/>
<property type="nucleotide sequence ID" value="XM_006712824.3"/>
</dbReference>
<dbReference type="PDB" id="6OF7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.11"/>
<property type="chains" value="B=1093-1212"/>
</dbReference>
<dbReference type="PDBsum" id="6OF7"/>
<dbReference type="PCDDB" id="O15055"/>
<dbReference type="SMR" id="O15055"/>
<dbReference type="BioGRID" id="114387">
<property type="interactions" value="31"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3219">
<property type="entry name" value="Cry1-Per2 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-3220">
<property type="entry name" value="Cry-Per2 complex"/>
</dbReference>
<dbReference type="DIP" id="DIP-38051N"/>
<dbReference type="IntAct" id="O15055">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000254657"/>
<dbReference type="BindingDB" id="O15055"/>
<dbReference type="ChEMBL" id="CHEMBL3751648"/>
<dbReference type="iPTMnet" id="O15055"/>
<dbReference type="PhosphoSitePlus" id="O15055"/>
<dbReference type="BioMuta" id="PER2"/>
<dbReference type="EPD" id="O15055"/>
<dbReference type="jPOST" id="O15055"/>
<dbReference type="MassIVE" id="O15055"/>
<dbReference type="MaxQB" id="O15055"/>
<dbReference type="PaxDb" id="O15055"/>
<dbReference type="PeptideAtlas" id="O15055"/>
<dbReference type="PRIDE" id="O15055"/>
<dbReference type="ProteomicsDB" id="48405">
<molecule id="O15055-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="48406">
<molecule id="O15055-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="34500">
<property type="antibodies" value="369 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="8864"/>
<dbReference type="Ensembl" id="ENST00000254657">
<molecule id="O15055-1"/>
<property type="protein sequence ID" value="ENSP00000254657"/>
<property type="gene ID" value="ENSG00000132326"/>
</dbReference>
<dbReference type="GeneID" id="8864"/>
<dbReference type="KEGG" id="hsa:8864"/>
<dbReference type="UCSC" id="uc002vyc.4">
<molecule id="O15055-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8864"/>
<dbReference type="DisGeNET" id="8864"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000132326.11"/>
<dbReference type="GeneCards" id="PER2"/>
<dbReference type="HGNC" id="HGNC:8846">
<property type="gene designation" value="PER2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000132326">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="PER2"/>
<dbReference type="MIM" id="603426">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="604348">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O15055"/>
<dbReference type="OpenTargets" id="ENSG00000132326"/>
<dbReference type="Orphanet" id="164736">
<property type="disease" value="Familial advanced sleep-phase syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33185"/>
<dbReference type="eggNOG" id="KOG3753">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156342"/>
<dbReference type="HOGENOM" id="CLU_006667_0_0_1"/>
<dbReference type="InParanoid" id="O15055"/>
<dbReference type="KO" id="K02633"/>
<dbReference type="OMA" id="SECIFCE"/>
<dbReference type="OrthoDB" id="145617at2759"/>
<dbReference type="PhylomeDB" id="O15055"/>
<dbReference type="TreeFam" id="TF318445"/>
<dbReference type="PathwayCommons" id="O15055"/>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="SIGNOR" id="O15055"/>
<dbReference type="BioGRID-ORCS" id="8864">
<property type="hits" value="10 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PER2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="PER2"/>
<dbReference type="GenomeRNAi" id="8864"/>
<dbReference type="Pharos" id="O15055">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:O15055"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="O15055">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000132326">
<property type="expression patterns" value="Expressed in oocyte and 244 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O15055">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O15055">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001222">
<property type="term" value="F:transcription corepressor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097167">
<property type="term" value="P:circadian regulation of translation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043153">
<property type="term" value="P:entrainment of circadian clock by photoperiod"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006631">
<property type="term" value="P:fatty acid metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006094">
<property type="term" value="P:gluconeogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005978">
<property type="term" value="P:glycogen biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070932">
<property type="term" value="P:histone H3 deacetylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019249">
<property type="term" value="P:lactate biosynthetic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042754">
<property type="term" value="P:negative regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070345">
<property type="term" value="P:negative regulation of fat cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031397">
<property type="term" value="P:negative regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000678">
<property type="term" value="P:negative regulation of transcription regulatory region DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0120162">
<property type="term" value="P:positive regulation of cold-induced thermogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="YuBioLab"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042752">
<property type="term" value="P:regulation of circadian rhythm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051946">
<property type="term" value="P:regulation of glutamate uptake involved in transmission of nerve impulse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050796">
<property type="term" value="P:regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050767">
<property type="term" value="P:regulation of neurogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019229">
<property type="term" value="P:regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002931">
<property type="term" value="P:response to ischemia"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009416">
<property type="term" value="P:response to light stimulus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050872">
<property type="term" value="P:white fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00130">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000014">
<property type="entry name" value="PAS"/>
</dbReference>
<dbReference type="InterPro" id="IPR035965">
<property type="entry name" value="PAS-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013655">
<property type="entry name" value="PAS_fold_3"/>
</dbReference>
<dbReference type="InterPro" id="IPR022728">
<property type="entry name" value="Period_circadian-like_C"/>
</dbReference>
<dbReference type="Pfam" id="PF08447">
<property type="entry name" value="PAS_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12114">
<property type="entry name" value="Period_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00091">
<property type="entry name" value="PAS"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55785">
<property type="entry name" value="SSF55785"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50112">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Period circadian protein homolog 2" id="PRO_0000162630">
<location>
<begin position="1"/>
<end position="1255"/>
</location>
</feature>
<feature type="domain" description="PAS 1" evidence="5">
<location>
<begin position="181"/>
<end position="248"/>
</location>
</feature>
<feature type="domain" description="PAS 2" evidence="5">
<location>
<begin position="321"/>
<end position="387"/>
</location>
</feature>
<feature type="domain" description="PAC">
<location>
<begin position="395"/>
<end position="438"/>
</location>
</feature>
<feature type="region of interest" description="Important for protein stability" evidence="2">
<location>
<begin position="480"/>
<end position="484"/>
</location>
</feature>
<feature type="region of interest" description="CSNK1E binding domain" evidence="2">
<location>
<begin position="557"/>
<end position="771"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PPARG" evidence="3">
<location>
<begin position="888"/>
<end position="1071"/>
</location>
</feature>
<feature type="region of interest" description="CRY binding domain" evidence="4">
<location>
<begin position="1155"/>
<end position="1255"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal 1" evidence="3">
<location>
<begin position="111"/>
<end position="120"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL">
<location>
<begin position="308"/>
<end position="312"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal 2" evidence="3">
<location>
<begin position="462"/>
<end position="471"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="3">
<location>
<begin position="789"/>
<end position="805"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal 3" evidence="3">
<location>
<begin position="989"/>
<end position="996"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL">
<location>
<begin position="1057"/>
<end position="1061"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Arg">
<location>
<begin position="510"/>
<end position="513"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="842"/>
<end position="979"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="527"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="530"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="533"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="540"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="662"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="696"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="700"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="714"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="766"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="771"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="945"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="977"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="1124"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_021653" evidence="14">
<original>RAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQSGGQPFDYSPIRFRARN</original>
<variation>SPAVRRAAFRLFSHSVSRPERRVHHVGHQLVQLHQPMEQENLLHHWEAQSQGGPFE</variation>
<location>
<begin position="349"/>
<end position="404"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_021654" evidence="14">
<location>
<begin position="405"/>
<end position="1255"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35572922." id="VAR_051575">
<original>A</original>
<variation>S</variation>
<location>
<position position="5"/>
</location>
</feature>
<feature type="sequence variant" description="In FASPS1; reduced in vitro phosphorylation by CSNK1E; dbSNP:rs121908635." id="VAR_029080" evidence="7">
<original>S</original>
<variation>G</variation>
<location>
<position position="662"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4429421." id="VAR_051576">
<original>V</original>
<variation>I</variation>
<location>
<position position="729"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_036041" evidence="9">
<original>L</original>
<variation>V</variation>
<location>
<position position="823"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35333999." id="VAR_051577">
<original>V</original>
<variation>I</variation>
<location>
<position position="903"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35998480." id="VAR_051578">
<original>F</original>
<variation>Y</variation>
<location>
<position position="949"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs934945." id="VAR_024558">
<original>G</original>
<variation>E</variation>
<location>
<position position="1244"/>
</location>
</feature>
<feature type="mutagenesis site" description="Restores CSNK1E-dependent phosphorylation of variant G-662." evidence="7">
<original>S</original>
<variation>D</variation>
<location>
<position position="662"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1136"/>
<end position="1140"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1145"/>
<end position="1149"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1158"/>
<end position="1171"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1181"/>
<end position="1188"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1192"/>
<end position="1196"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="1201"/>
<end position="1203"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6OF7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O54943"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Z301"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00140"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11165242"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11232563"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14750904"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22274616"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24202686"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30530698"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9427249"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000303">
<source ref="1"/>
</evidence>
<evidence key="15" type="ECO:0000305"/>
<sequence length="1255" mass="136579" checksum="2AEF2C6BD4B6CBB0" modified="2001-07-11" version="2">MNGYAEFPPSPSNPTKEPVEPQPSQVPLQEDVDMSSGSSGHETNENCSTGRDSQGSDCDDSGKELGMLVEPPDARQSPDTFSLMMAKSEHNPSTSGCSSDQSSKVDTHKELIKTLKELKVHLPADKKAKGKASTLATLKYALRSVKQVKANEEYYQLLMSSEGHPCGADVPSYTVEEMESVTSEHIVKNADMFAVAVSLVSGKILYISDQVASIFHCKRDAFSDAKFVEFLAPHDVGVFHSFTSPYKLPLWSMCSGADSFTQECMEEKSFFCRVSVRKSHENEIRYHPFRMTPYLVKVRDQQGAESQLCCLLLAERVHSGYEAPRIPPEKRIFTTTHTPNCLFQDVDERAVPLLGYLPQDLIETPVLVQLHPSDRPLMLAIHKKILQSGGQPFDYSPIRFRARNGEYITLDTSWSSFINPWSRKISFIIGRHKVRVGPLNEDVFAAHPCTEEKALHPSIQELTEQIHRLLLQPVPHSGSSGYGSLGSNGSHEHLMSQTSSSDSNGHEDSRRRRAEICKNGNKTKNRSHYSHESGEQKKKSVTEMQTNPPAEKKAVPAMEKDSLGVSFPEELACKNQPTCSYQQISCLDSVIRYLESCNEAATLKRKCEFPANVPALRSSDKRKATVSPGPHAGEAEPPSRVNSRTGVGTHLTSLALPGKAESVASLTSQCSYSSTIVHVGDKKPQPELEMVEDAASGPESLDCLAGPALACGLSQEKEPFKKLGLTKEVLAAHTQKEEQSFLQKFKEIRKLSIFQSHCHYYLQERSKGQPSERTAPGLRNTSGIDSPWKKTGKNRKLKSKRVKPRDSSESTGSGGPVSARPPLVGLNATAWSPSDTSQSSCPAVPFPAPVPAAYSLPVFPAPGTVAAPPAPPHASFTVPAVPVDLQHQFAVQPPPFPAPLAPVMAFMLPSYSFPSGTPNLPQAFFPSQPQFPSHPTLTSEMASASQPEFPSRTSIPRQPCACPATRATPPSAMGRASPPLFQSRSSSPLQLNLLQLEEAPEGGTGAMGTTGATETAAVGADCKPGTSRDQQPKAPLTRDEPSDTQNSDALSTSSGLLNLLLNEDLCSASGSAASESLGSGSLGCDASPSGAGSSDTSHTSKYFGSIDSSENNHKAKMNTGMEESEHFIKCVLQDPIWLLMADADSSVMMTYQLPSRNLEAVLKEDREKLKLLQKLQPRFTESQKQELREVHQWMQTGGLPAAIDVAECVYCENKEKGNICIPYEEDIPSLGLSEVSDTKEDENGSPLNHRIEEQT</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

